65,437 trials
Leukemia · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Primary: MRD Cohort: 1-Year Disease-Free Survival (DFS) Rate in Confirmed uMRD Randomized Participants — 100.0; 95.3 percentage of participants — p=0.1475
Hyperlipidemia
Primary: Percentage of Participants (Cumulative Incidence) With Specified Cardiovascular Events in Population of Omega-3 Fatty Acid Ethyl Esters 2 g User — 0.0; 0.5; 1.1; 1.4…
Malaria
Primary: Efficacy of the RH5.1/AS01 Vaccine by Demonstrating a Reduced PMR in Vaccinated Subjects Compared to Infectivity Controls Against 3D7 Clone Parasites in a CHMI Model…
Hepatitis B Vaccination
Primary: Number and Rate of Participants With Anti-HBs Seroconversion at Month 7 — 142; 138; 0 Participants
Sarcoidosis, Pulmonary · Sarcoidosis Lung · Sarcoidosis
Primary: Number of Participants With 50% Reduction in Corticosteroid Requirement — 3 Participants
COVID-19 · SARS-CoV-2
Primary: Change in Oxygenation Parameter of P(A-a)O2 Gradient by Day 6 — -102.3; -30.5 millimeters of mercury (mmHg)
PTSD
Primary: Change in PTSD Symptoms (as Measured by the PCL-5) — 31.4 score on a scale — p=<.001
Depression
Primary: Medication Adherence at Baseline, 6 Weeks and 12 Weeks — 3.41; 1.32; 2.55; 2.66 score on a scale — p=0.10
Hypertension · COVID-19
Primary: Level of BP in mm Hg — 136; 138; 34; 82 mm Hg
Infertility, Female
Primary: the Number of M2 Oocytes Retrieved — 6; 4.5 oocytes — p=0.254
Post-operative Urinary Retention
Primary: Number of Patients Who Undergo Postoperative Catheterization for Urinary Retention — 23; 25 Participants — p=.96
Hearing Loss
Primary: Subjective Listening Effort Scaling — -2.276; -0.917 SNR (dB)
Stroke · Ischemic Attack, Transient
Primary: Adherence With Home Blood Pressure Monitoring, Defined by the Proportion of Home Blood Pressure Recordings Successfully Completed — 40; 60 percentage of requested BP…
Prostate Cancer
Primary: Prostate Specific Antigen (PSA) Response Rate — 6 Participants
Cystic Fibrosis
Primary: Time to First Pulmonary Exacerbation — NA; NA Weeks